Subtype specific internalization of P2Y1 and P2Y2 receptors induced by novel adenosine 5′‐O‐(1‐boranotriphosphate) derivatives
- 1 July 2004
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 142 (5) , 869-878
- https://doi.org/10.1038/sj.bjp.0705859
Abstract
P2Y‐nucleotide receptors represent important targets for drug development. The lack of stable and receptor specific agonists, however, has prevented successful therapeutic applications. A novel series of P‐boronated ATP derivatives (ATP‐α‐B) were synthesized by substitution of a nonbridging O at P with a BH3 group. This introduces a chiral center, thus resulting in diastereoisomers. In addition, at C2 of the adenine ring a further substitution was made (Cl‐ or methylthio‐). The pairs of diastereoisomers were denoted here as A and B isomers. Here, we tested the receptor subtype specificity of these analogs on HEK 293 cells stably expressing rat P2Y1 and rat P2Y2 receptors, respectively, both attached to the fluorescent marker protein GFP (rP2Y1‐GFP, rP2Y2‐GFP). We investigated agonist‐induced receptor endocytosis, [Ca2+]i rise and arachidonic acid (AA) release. Agonist‐induced endocytosis of rP2Y1‐GFP was more pronounced for the A isomers than the corresponding B counterparts for all ATP‐α‐B analogs. Both 2‐MeS‐substituted diastereoisomers induced a greater degree of agonist‐induced receptor endocytosis as compared to the 2‐Cl‐substituted derivatives. Endocytosis results are in accordance with the potency to induce Ca2+ release by these compounds in HEK 293 cells stably transfected with rP2Y1. In case of rP2Y2‐GFP, the borano‐nucleotides were very weak agonists in comparison to UTP and ATP in terms of Ca2+ release, AA release and in inducing receptor endocytosis. The different ATP‐α‐B derivatives and also the diastereoisomers were equally ineffective. Thus, the new agonists may be considered as potent and highly specific agonist drug candidates for P2Y1 receptors. The difference in activity of the ATP analogs at P2Y receptors could be used as a tool to investigate structural differences between P2Y receptor subtypes. British Journal of Pharmacology (2004) 142, 869–878. doi:10.1038/sj.bjp.0705859Keywords
This publication has 58 references indexed in Scilit:
- Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor familyTrends in Pharmacological Sciences, 2003
- Endocytosed Transferrin Receptors Recycle via Distinct Dynamin and Phosphatidylinositol 3-Kinase-dependent PathwaysJournal of Biological Chemistry, 2002
- Adenosine 5‘-O-(1-Boranotriphosphate) Derivatives as Novel P2Y1 Receptor AgonistsJournal of Medicinal Chemistry, 2002
- Extracellular ATP and UTP activate the protein kinase B/Akt cascade via the P2Y2 purinoceptor in renal mesangial cellsBritish Journal of Pharmacology, 2002
- β2-Adrenergic Receptor Down-regulationPublished by Elsevier ,1999
- β-Arrestins Regulate Interleukin-8-induced CXCR1 InternalizationJournal of Biological Chemistry, 1999
- Visualization of Agonist-induced Sequestration and Down-regulation of a Green Fluorescent Protein-tagged β2-Adrenergic ReceptorPublished by Elsevier ,1998
- Human Muscarinic Cholinergic Receptor Hm1 Internalizes via Clathrin-coated VesiclesPublished by Elsevier ,1996
- Cloning and Functional Expression of a Human Uridine Nucleotide ReceptorJournal of Biological Chemistry, 1995
- Cloning and functional expression of a brain G‐protein‐coupled ATP receptorFEBS Letters, 1993